Evidence map›Paper›PMID 40343044›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Automated Deep Learning Pipeline for Characterizing Left Ventricular Diastolic Function.

Victoria Yuan, Yuki Sahashi, Hirotaka Ieki, Miloš Vukadinovic, Christina Binder, Konrad Pieszko, Andrew P Ambrosy, Paul P Cheng, Susan Cheng, David Ouyang

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Victoria YuanDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Yuki SahashiDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Hirotaka IekiDivision of Cardiology, Department of Medicine, Stanford University, Palo Alto, CA.
Miloš VukadinovicDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Christina BinderDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Konrad PieszkoDepartment of Interventional Cardiology and Cardiac Surgery, University of Zielona Gora, Collegium Medicum, Zielona Gora, Poland.
Andrew P AmbrosyDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA.
Paul P ChengDivision of Cardiology, Department of Medicine, Stanford University, Palo Alto, CA.
Susan ChengDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
David OuyangDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Funding

Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart DiseaseR01HL173526 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI David Ouyang · 2024 to 2026
$2.5M
Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular StressR01HL173487 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI David Ouyang · 2025 to 2026
$1.4M
Deep Learning Assessment of the Right Ventricle: Function, Etiology, and PrognosisR00HL157421 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI OUYANG, DAVID · 2023 to 2025
$747k
NHLBI NIH HHS R00 HL157421NHLBI NIH HHS R01 HL173487NHLBI NIH HHS R01 HL173526
6 · The paper itself

Abstract

Introduction: Left ventricular diastolic dysfunction (LVDD) is most commonly evaluated by echocardiography. However, without a sole identifying metric, LVDD is assessed by a diagnostic algorithm relying on secondary characteristics that is laborious and has potential for interobserver variability. Methods: To characterize concordance in clinical evaluations of LVDD, we evaluated historical echocardiogram studies at two academic medical centers for variability between clinician text reports and assessment by 2016 American Society of Echocardiography (ASE) guidelines. We then developed a workflow of 8 artificial intelligence (AI) models trained on over 155,000 studies to automate assessment of LVDD. Model performance was evaluated on temporally distinct held-out test sets from two academic medical centers. Results: In a validation cohort of 955 studies from Cedars-Sinai Medical Center, our AI workflow demonstrated 76.5% agreement and a weighted Cohen's kappa of 0.52 with ASE guideline assessment using human measurements. In contrast, the clinician report evaluation had 48.5% agreement and a weighted Cohen's kappa of 0.29 with ASE guidelines. In the Stanford Healthcare cohort of 1,572 studies, the AI workflow had 66.7% agreement and a weighted Cohen's kappa of 0.27 with ASE guidelines, while the clinician assessment had 32.7% agreement and a weighted Cohen's kappa of 0.06. Performance was consistent across patient subgroups stratified by sex, age, hypertension, diabetes, obesity, and coronary artery disease. Conclusion: Clinicians are often inconsistent in evaluating LVDD. We developed an AI pipeline that automates the clinical workflow of grading LVDD, which can contribute to improved diagnosis of heart failure.

Identifiers

PMID40343044
PMCPMC12060936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.